Статья
Кардиомиопатия такоцубо. Обзор данных литературы: понятие, эпидемиология, патогенез. Часть I
В обзоре представлены современные данные по проблеме кардиомиопатии такоцубо, затронуты основные вопросы эпидемиологии, клинической картины, критериев диагностики, а также общие патофизиологические механизмы развития заболевания.
1. Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur. Heart J. 2018;39:2032-46. doi:10.1093/eurheartj/ehy076.
2. Меерсон Ф.З. Патогенез и предупреждение стрессорных и ишемических повреждений сердца. М.: Медицина, 1984. p.269.
3. Amin HZ, Amin LZ, Pradipta A. Takotsubo Cardiomyopathy: A Brief Review. J Med Life. 2020;13(1):3-7. doi:10.25122/jml-2018-0067.
4. Templin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N. Engl. J. Med. 2015;373:929-38. doi:10.1056/NEJMoa1406761.
5. Jabri A, Kalra A, Kumar A, et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780. doi:10.1001/jamanetworkopen.2020.14780.
6. Napp LC, Bauersachs J. Takotsubo syndrome: between evidence, myths, and misunderstandings. Herz. 2020;45(3):252-66. doi:10.1007/s00059-020-04906-2.
7. Rawish E, Stiermaier T, Santoro F, et al. Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis. J Clin Med. 2021;10(3):479. doi:10.3390/jcm10030479.
8. Citro R, Radano I, Parodi G, et al. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction. Eur J Heart Fail. 2019;21(6):781-9. doi:10.1002/ejhf.1373.
9. Болдуева С. А., Третьякова Н. С., Швец Н. С., Феоктистова В. С. Развитие синдрома такоцубо в период госпитализации по поводу тромбоэмболии легочной артерии: клиническое наблюдение. Кардиология. 2018;58(3S):64-8. doi:10.18087/cardio.2452.
10. Мазнев Д.С., Болдуева С.А., Задворьев С.Ф. и др. Синдром такоцубо в сочетании с инфарктом миокарда 2-го типа у пациентки пожилого возраста с коронавирусной инфекцией. Профилактическая медицина. 2021;24(11):80-6. doi:10.17116/profmed20212411180.
11. Suzuki H, Matsumoto Y, Kaneta T, et al. Evidence for brain activation in patients with takotsubo cardiomyopathy. Circ J. 2014;78(1):256-8. doi:10.1253/circj.cj-13-1276.
12. Wang X, Pei J, Hu X. The Brain-Heart Connection in Takotsubo Syndrome: The Central Nervous System, Sympathetic Nervous System, and Catecholamine Overload. Cardiol Res Pract. 2020:4150291. doi:10.1155/2020/4150291.
13. Hiestand T, Hänggi J, Klein C, et al. Takotsubo Syndrome Associated With Structural Brain Alterations of the Limbic System. J Am Coll Cardiol. 2018;71(7):809-11. doi:10.1016/j.jacc.2017.12.022.
14. Klein C, Hiestand T, Ghadri JR, et al. Takotsubo Syndrome - Predictable from brain imaging data. Sci Rep. 2017;7(1):5434. doi:10.1038/s41598-017-05592-7.
15. Templin C, Hänggi J, Klein C, et al. Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome. Eur Heart J. 2019;40(15):1183-7. doi:10.1093/eurheartj/ehz068.
16. Summers MR, Lennon RJ, Prasad A. Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential predisposing factors? J Am Coll Cardiol. 2010;55(7):700-1. doi:10.1016/j.jacc.2009.10.031.
17. Barton DA, Dawood T, Lambert EA, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens. 2007;25:2117-24. doi:10.1097/HJH.0b013e32829baae7.
18. Sciagrà R, Parodi G, Del Pace S, et al. Abnormal response to mental stress in patients with Takotsubo cardiomyopathy detected by gated single photon emission computed tomography. Eur J Nucl Med Mol Imaging. 2010;37(4):765-72. doi:10.1007/s00259-009-1362-z.
19. Akashi YJ, Nakazawa K, Sakakibara M, et al. The clinical features of takotsubo cardiomyopathy. QJM. 2003;96(8):563-73. doi:10.1093/qjmed/hcg096.
20. Okura H. Update of takotsubo syndrome in the era of COVID-19. J Cardiol. 2021;77(4):361- 9. doi:10.1016/j.jjcc.2020.10.004.
21. Paur H, Wright PT, Sikkel MB, et al. High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a β2-Adrenergic Receptor/Gi–Dependent Manner. Circulation. 2012;126:697-706. doi:10.1161/circulationaha.112.111591.
22. Gurevich VV, Gurevich EV. GPCR Signaling Regulation: The Role of GRKs and Arrestins. Front Pharmacol. 2019;10:125. doi:10.3389/fphar.2019.00125.
23. Nakano T, Onoue K, Nakada Y, et al. Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study. Sci Rep. 2018;8(1):12731. doi:10.1038/s41598-018-31034-z.
24. Болезни сердца по Браунвальду: руководство по сердечно-сосудистой медицине, Под ред. П. Либби и др.; пер. с англ., под общ. ред. Р. Г. Оганова. В 4т. Том3: главы 38-60. М.: Логосфера, 2013. 728с.: Перевод изд. ISBN: 978-5-98657-029-7.
25. Bolli R, Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79(2):609-34. doi:10.1152/physrev.1999.79.2.609.
26. Kumar A, Pappachan JM, Fernandez CJ. Catecholamine-induced cardiomyopathy: an endocrinologist’s perspective. Rev Cardiovasc Med. 2021;22(4):1215-28. doi:10.31083/j.rcm2204130.
27. Manousek J, Kala P, Lokaj P, et al. Oxidative Stress in Takotsubo Syndrome-Is It Essential for an Acute Attack? Indirect Evidences Support Multisite Impact Including the Calcium Overload-Energy Failure Hypothesis. Front Cardiovasc Med. 2021;8:732708. doi:10.3389/fcvm.2021.732708.
28. Malyshev IY, Manukhina EB. Stress, adaptation, and nitric oxide. Biochemistry (Mosc). 1998;63(7):840-53.
29. El-Battrawy I, Zhao Z, Lan H, et al. Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes. Int J Cardiol. 2018;254:195-202. doi:10.1016/j.ijcard.2017.11.007.
30. Brenner R, Weilenmann D, Maeder MT, et al. Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy. Clin Cardiol. 2012;35(6):340-7. doi:10.1002/clc.21986.
31. Surikow SY, Nguyen TH, Stafford I, et al. Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome. JACC Basic Transl Sci. 2018;3(2):213-26. doi:10.1016/j.jacbts.2017.10.002.
32. Hartmann C, Radermacher P, Wepler M, Nußbaum B. Non-Hemodynamic Effects of Catecholamines. Shock. 2017;48(4):390-400. doi:10.1097/SHK.0000000000000879.
33. Patel SM, Lerman A, Lennon RJ, Prasad A. Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy). Eur Heart J Acute Cardiovasc Care. 2013;2(2):147-52. doi:10.1177/2048872613475891.
34. Del Buono MG, Montone RA, Camilli M, et al. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(13):1352-71. doi:10.1016/j.jacc.2021.07.042.
35. Литвицкий П.Ф., Сандриков В.А., Демуров Е.А. Адаптивные и патогенные эффекты реперфузии и реоксигенации миокарда. М.: Медицина, 1994. р. 318. ISBN: 5-225-02888-8.
36. Vitale C, Rosano GM, Kaski JC. Role of Coronary Microvascular Dysfunction in Takotsubo Cardiomyopathy. Circ J. 2016;80(2):299-305. doi:10.1253/circj.CJ-15-1364.
37. Болдуева С.А., Рыжикова М.В., Швец Н. С. и др. Синдром такоцубо как острая форма микроваскулярной стенокардии. Описание клинического случая. Рациональная фармакотерапия в кардиологии 2017;13(4):489-94. doi:10.20996/1819-6446-2017-13-4-489-494.
38. Yalta K, Yetkin E, Yalta T. Systemic inflammation in patients with Takotsubo syndrome: a review of mechanistic and clinical implications. Monaldi Arch Chest Dis. 2021;91(2):10.4081/monaldi.2021.1718. doi:10.4081/monaldi.2021.1718.
39. Lachmet-Thébaud L, Marchandot B, Matsushita K, et al. Systemic Inflammatory Response Syndrome Is a Major Determinant of Cardiovascular Outcome in Takotsubo Syndrome. Circ J. 2020;84(4):592-600. doi:10.1253/circj.CJ-19-1088.
40. Scally C, Abbas H, Ahearn T, et al. Myocardial and Systemic Inflammation in Acute StressInduced (Takotsubo) Cardiomyopathy. Circulation. 2019;139:1581-92. doi:10.1161/CIRCULATIONAHA.118.037975.
41. Wilson HM, Cheyne L, Brown PAJ, et al. Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy. JACC Basic Transl. Sci. 2018;3:766-78. doi:10.1016/j.jacbts.2018.08.006.
42. Chen Q, Zhang W, Sadana N, Chen X. Estrogen receptors in pain modulation: cellular signaling. Biol Sex Differ. 2021;12(1):22. doi:10.1186/s13293-021-00364-5.
43. Omerovic E, Citro R, Bossone E, et al. Pathophysiology of Takotsubo syndrome — a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology — Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications. Eur J Heart Fail. 2022;24(2):274-286. doi:10.1002/ejhf.2368.
44. Machuki JO, Zhang HY, Harding SE, Sun H. Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value. Acta Physiol (Oxf). 2018;222(2):e12978. doi:10.1111/apha.12978.
45. Boyd B, Solh T. Takotsubo cardiomyopathy: Review of broken heart syndrome. JAAPA. 2020;33(3):24-9. doi:10.1097/01.JAA.0000654368.35241.fc.
46. Möller C, Stiermaier T, Brabant G, et al. Comprehensive assessment of sex hormones in Takotsubo syndrome. Int J Cardiol. 2018;250:11-5. doi:10.1016/j.ijcard.2017.10.047.
47. Rueda D, Aguirre R, Contardo D, et al. Takotsubo Myocardiopathy and Hyperthyroidism: A Case Report and Literature Review. Am J Case Rep. 2017;18:865-70. doi:10.12659/ajcr.905121.
48. Balsa AM, Ferreira AR, Alves M, Guimarães J. Takotsubo Cardiomyopathy Associated with Levothyroxine Over-replacement. Eur Endocrinol. 2017;13(1):30-2. doi:10.17925/EE.2017.13.01.30.
49. Aweimer A, El-Battrawy I, Akin I, et al. Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. J Intern Med. 2021;289(5):675-87. doi:10.1111/joim.13189.
50. Madias JE. Low prevalence of diabetes mellitus in patients with takotsubo syndrome: a plausible "protective" effect with pathophysiologic connotations. European Heart Journal: Acute Cardiovascular Care. 2016;5(2):164-70. doi:10.1177/2048872615570761.
51. Kato K, Sakai Y, Ishibashi I, et al. Predictors of in-hospital cardiac complications in patients with Takotsubo syndrome. Heart Vessels. 2018;33(10):1214-9. doi:10.1007/s00380-018-1172-y.
52. Núñez-Gil IJ, Vedia O, Almendro-Delia M, et al. Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO. Implicaciones clínicas y pronósticas en síndrome de Takotsubo y cáncer: percepciones del registro RETAKO. Med Clin (Barc). 2020;155(12):521-8. doi:10.1016/j.medcli.2020.01.033.
53. Yerasi C, Tripathi B, Banga S, et al. Predictors of 90-Day Readmission and in-Hospital Mortality in Takotsubo Cardiomyopathy: An Analysis of 28,079 Index Admissions. Cardiovasc Revasc Med. 2019;20(11):973-9. doi:10.1016/j.carrev.2019.08.004.
54. Mitchell A, Marquis F. Can Takotsubo cardiomyopathy be diagnosed by autopsy? Report of a presumed case presenting as cardiac rupture. BMC Clin Pathol. 2017;17:4. doi:10.1186/s12907-017-0045-0.
55. Aoki Y, Kodera S, Watanabe T, et al. Autopsy findings in takotsubo cardiomyopathy with special reference to the autonomic nervous system. Int J Cardiol. 2016;203:236-7. doi:10.1016/j.ijcard.2015.10.121.
56. Konishi T, Funayama N, Yamamoto T, et al. Acute anterior myocardial infarction complicated by takotsubo syndrome: the value of multimodality imaging. Kardiol Pol. 2020;78(10):1055-6. doi:10.33963/KP.15492.